Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000210426
Citations
3
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
4.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)

Timothy Peters-Strickland, Cassandra Snipes, Olya Besedina, Alexander Kuka et al.
3 citations
Neurology
Migraine and Headache Studies
4.41
article

Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)

Timothy Peters-Strickland, Cassandra Snipes, Olya Besedina, Alexander Kuka, Stewart J. Tepper, Shaheen Emmanuel Lakhan, Laura Taraboanta, Mariya Petrova
article en
3 citations

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
New England Institute for Neurology and Headache (US)
Good health and well-being
Openalex Percentile: Top 6%
Migraine and Headache Studies
4.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.